https://www.selleckchem.com/pr....oducts/fingolimod.ht
Problems within schemes included health provider engagement, recruiting those with low agency and communication between professionals and patients about social prescribing. Based on our findings, we propose a number of recommendations for enhancing social prescribing schemes. Professionals, including neurologists, we argue, can benefit from engaging in the concept and practice of social prescribing and referring patients and clients to social prescribing link workers where appropriate. Neurologists are also part of a larger team, as